Search
Immunocore Holdings PLC
IMCRAdd to Watchlist
29.790USD
-0.700-2.30%
Close 11-02 16:00（ET）
1.53BMarket Cap
LossP/E TTM
Immunocore Holdings PLC (IMCR) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Immunocore Holdings PLC in the past month.
Buy
2 Strong Buy
7 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
67.583USD+107.25%
IMCR Analyst Recommendation Trends
In the current month, IMCR has received 7 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. IMCR average Analyst price target in the last month is 67.583.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
3
4
4
5
5
5
5
7
7
8
7
7
8
8
8
4
4
4
4
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
14
16
15
16
17
17
17
IMCR Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
10
17
10
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
5
18
9
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
15
9
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, IMCR EPS is projected to reach -0.135 in FY2026Q3, following reported EPS of -0.016 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.24
-0.26
0.01
-0.13
-0.17
Actual
-0.59
0.26
-0.02
--
--
Surprise
-144.29%
+198.58%
-253.73%
--
--
FAQs
What is Immunocore Holdings PLC's expected revenue for the next quarter?
Immunocore Holdings PLC's expected revenue is 113.44M.
What is Immunocore Holdings PLC's price target?
Analysts forecast that Immunocore Holdings PLC's price target is USD 66.45, with the highest forecast at USD 100.00 and the lowest forecast at USD 34.00.
How have Immunocore Holdings PLCIMCR's recent earnings per share performed?
The market expectation was USD -0.02, while Immunocore Holdings PLCIMCR's earnings per share (EPS) for the previous quarter was USD 0.26. EPS for the next quarter is expected at USD -0.13.
What is the analyst rating for Immunocore Holdings PLC?
Based on the ratings of Immunocore Holdings PLC's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.